USFDA has issued notice to the Hyderabad unit of Aurobindo Pharma and calming the nerves of the investors Surajit Pal of Prabhudas Lilladher says that it is a non-event and there is no need to worry.
first published: Dec 20, 2016 10:50 am
A collection of the most-viewed Moneycontrol videos.

How you can invest in foreign stocks from India

6 Behavioural Biases Every Investor Must Avoid | Improve Your Investment Outcomes

Nifty Fails To Defend 25,900 Amid Choppy Trade On Sensex Expiry; AMC Stocks Surge| Closing Bell Live

Markets Brace For More Weakness On Sensex Expiry; SEBI Revamps MF Expense Norms| Opening Bell Live
You are already a Moneycontrol Pro user.

